Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cerevel Therapeutics Holdings Inc CERE

Healthcare Biotechnology
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients... see more

Recent & Breaking News (NDAQ:CERE)

NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm

PR Newswire 10 hours ago

ACQUISITION ALERT BFA LLP Notifies Cerevel Therapeutics Shareholders of an Investigation into the Merger with AbbVie

Accesswire 4 days ago

BFA LLP Reminds Cerevel Therapeutics Shareholders of the Investigation into Merger with AbbVie and Encourages Investors to Contact the Firm

Newsfile 4 days ago

MERGER NEWS NASDAQ CERE BFA Law Investigates Cerevel Therapeutics Merger with AbbVie Encourages Shareholders to Contact the Firm

Accesswire 5 days ago

MERGER ALERT CERE Is $45 per CERE Share Fair? Top Law Firm BFA LLP Investigating Cerevel Therapeutics Merger with AbbVie

Newsfile 5 days ago

NASDAQ CERE INVESTIGATION ALERT Leading Law Firm BFA LLP Notifies CERE Shareholders of Investigation into the Cerevel Therapeutics Merger with AbbVie Contact Firm for More Information

Accesswire 6 days ago

CEREVEL THERAPEUTICS HOLDINGS, INC. (CERE) ACQUISITION ALERT: Is AbbVie Inc.'s Offer of $45 per CERE Share a Fair Deal? Bleichmar Fonti & Auld LLP is Currently Investigating the Acquisition

Newsfile 6 days ago

BUYOUT INVESTIGATION ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) and Encourages Investors to Contact the Firm

Accesswire 11 days ago

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease

GlobeNewswire April 18, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE

PR Newswire January 29, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, CERE, PGTI, FGH

Accesswire January 27, 2024

CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE

PR Newswire January 26, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Cerevel Therapeutics Holdings, Inc. (CERE)

Newsfile January 26, 2024

Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm

PR Newswire January 24, 2024

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, SIX, CERE, EGLE

PR Newswire January 23, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Cerevel Therapeutics Holdings, Inc. (CERE)

Newsfile January 22, 2024

CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders

Business Wire January 8, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RYZB, KRTX, GRCL, CERE

Accesswire January 4, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIA, CERE, BRBS, AYX

PR Newswire January 3, 2024

Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law Firm

PR Newswire January 2, 2024